- Predictors/Trajectories of Depressive Symptoms in Asthma, From Youth to Adulthood
- Elexacaftor/Tezacaftor/Ivacaftor Safe, Well Tolerated in Pediatric CF
- COVID-19 Pandemic Created Challenges for Interpreting Trends in Cancer Incidence
- Routine Immunologic Testing Beneficial for Children With Severe Bacterial Infections
- US COVID-19 Hospitalizations Reach Record Low
- Sleep Apnea Severity in Black Patients May Be Underestimated Using Standard Tests
- Fracture Risk Up With Prediabetes Before Menopause Transition
- Robotic-Assisted Medial Knee Arthroplasty Tied to Good Long-Term Outcomes
- Use of Mesenchymal Stromal Cells Is Safe But Not Effective in COVID-19 ARDS
- Cystic Fibrosis Care Gaps of 1 Year or More Linked to Decreased Lung Function
- Paxlovid Receives FDA Approval for COVID-19 Treatment
- Weight Fluctuations May Increase Cardiovascular Risk in Individuals With Type 2 Diabetes
Clinical Tools
Powered by
Powered by 
Relapse and Mortality Characteristics Identified for Adolescent Acquired Thrombotic Thrombocytopenic Purpura
Racial, Ethnic Inequities Identified in Opioid Access for Patients Dying of Cancer
Long COVID Explored in University Settings
Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure
Jaypirca Approved for Relapsed/Refractory Mantle Cell Lymphoma
